Trade Names: | |
Synonyms: | |
Status: | Approved (1986) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | PML56A160O |
Parent Compound: | GUANFACINE |
InChI Key | DGFYECXYGUIODH-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C9H10Cl3N3O |
Molecular Weight | 282.56 |
AlogP | 1.55 |
Hydrogen Bond Acceptor | 2.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 78.97 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 15.0 |
Action | Mechanism of Action | Reference |
---|---|---|
AGONIST | Adrenergic receptor alpha-2 agonist | DailyMed |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Attention Deficit Disorder with Hyperactivity | 4 | D001289 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 5559 |
ChEMBL | CHEMBL1200494 |
EPA CompTox | DTXSID2045157 |
FDA SRS | PML56A160O |
KEGG | C07037 |
PubChem | 71401 |
SureChEMBL | SCHEMBL41681 |
ZINC | ZINC03872738 |